Uniswen Pharmaceuticals Private Limited
Pharmaceutical company specializing in marketing, manufacturing, and distribution of pharmaceutical products and chemicals.
2016 | Pune, Maharashtra (India) | Active
Uniswen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 33.98%
- Profit Growth -14062.17%
- Ebitda -321.22%
- Net Worth -570.52%
- Total Assets -59.68%
About Uniswen Pharmaceuticals
Uniswen Pharmaceuticals Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2016 (Eight years and ten months 25 days old ). Its registered office is in Pune, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Pandit Ghorpade, Rajendra Dixit, Shailesh Phaldessai, and One other member serve as directors at the Company.
Company Details
- Location Pune, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100PN2016PTC164976
- Company No.
164976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2016
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Pharma
Uniswen Pharmaceuticals Private Limited
Explore comprehensive data for Uniswen Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Uniswen Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pandit Ghorpade  | Director | 14-Jun-2016 | Current |
| Rajendra Dixit | Director | Current | |
| Shailesh Phaldessai | Director | 14-Jun-2016 | Current |
| Yashwant Bhujbal | Additional Director | Current |
Financial Performance of Uniswen Pharmaceuticals.
Uniswen Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 33.98% increase. The company also saw a substantial fall in profitability, with a 14062.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 570.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uniswen Pharmaceuticals?
Unlock access to Uniswen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Specura Pharmaceuticals Private Limited
Rajendra Dixit and Yashwant Bhujbal are mutual person
- Garphapona Foundation
Shailesh Phaldessai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Uniswen Pharmaceuticals?
Unlock and access historical data on people associated with Uniswen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uniswen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniswen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Uniswen Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Uniswen Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
- Balance Sheet
Uniswen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Pune.
- Director Appointment
Pandit Vilasrao Ghorpade was appointed as a Director was appointed as a Director on 14 Jun 2016 & has been associated with this company since 8 years 10 months .
- Director Appointment
Shailesh Shashikant Phaldessai was appointed as a Director was appointed as a Director on 14 Jun 2016 & has been associated with this company since 8 years 10 months .
- Company Incorporation
Uniswen Pharmaceuticals Private Limited was registered on 14 Jun 2016 with Roc Pune & aged 8 years 10 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Uniswen Pharmaceuticals Private Limited?
Uniswen Pharmaceuticals Private Limited was incorporated on 14 Jun 2016.
What is authorized share capital and paid-up capital of Uniswen Pharmaceuticals Private Limited?
The authorized share capital of Uniswen Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Uniswen Pharmaceuticals Private Limited?
Currently 4 directors are associated with Uniswen Pharmaceuticals Private Limited.
- Pandit Vilasrao Ghorpade
- Rajendra Chandrashekhar Dixit
- Shailesh Shashikant Phaldessai
- Yashwant Shivram Bhujbal
What is the registered address of Uniswen Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Uniswen Pharmaceuticals Private Limited is Sno 82 7A7B8 Bldg No D4/5 Guru Ganesh Nagar, Kothrud India, Pune, Maharashtra, 411029.
What is the corporate identification number (CIN) and company number of Uniswen Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Uniswen Pharmaceuticals Private Limited is U85100PN2016PTC164976 and the company number is 164976 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Uniswen Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Uniswen Pharmaceuticals Private Limited has risen by 33.98%.
What change has been observed in the net worth of Uniswen Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Uniswen Pharmaceuticals Private Limited has experienced an downturn of -570.52%.
When was the last Balance Sheet of Uniswen Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Uniswen Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2020.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records